Cargando…
Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS
BACKGROUND: Septic shock is characterized by breakdown of the endothelial glycocalyx and endothelial damage, contributing to fluid extravasation, organ failure and death. Albumin has shown benefit in septic shock patients. Our aims were: (1) to identify the relations between circulating levels of sy...
Autores principales: | Piotti, Arianna, Novelli, Deborah, Meessen, Jennifer Marie Theresia Anna, Ferlicca, Daniela, Coppolecchia, Sara, Marino, Antonella, Salati, Giovanni, Savioli, Monica, Grasselli, Giacomo, Bellani, Giacomo, Pesenti, Antonio, Masson, Serge, Caironi, Pietro, Gattinoni, Luciano, Gobbi, Marco, Fracasso, Claudia, Latini, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980645/ https://www.ncbi.nlm.nih.gov/pubmed/33741039 http://dx.doi.org/10.1186/s13054-021-03545-1 |
Ejemplares similares
-
Septic shock-3 vs 2: an analysis of the ALBIOS study
por: Vasques, Francesco, et al.
Publicado: (2018) -
Proposed benefits of albumin from the ALBIOS trial: a dose of insane belief
por: Caironi, Pietro, et al.
Publicado: (2014) -
Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial
por: Alagna, Laura, et al.
Publicado: (2021) -
Compared values of presepsin (sCD14-ST) and procalcitonin as early markers of outcome in severe sepsis and septic shock: a preliminary report from the Albumin Italian Outcome Sepsis (ALBIOS) study
por: Caironi, P, et al.
Publicado: (2013) -
Development of a Critical Care Response - Experiences from Italy During the Coronavirus Disease 2019 Pandemic
por: Rezoagli, Emanuele, et al.
Publicado: (2021)